DISSEMINATED HISTOPLASMOSIS AFTER VEDOLIZUMAB USE FOR ULCERATIVE COLITIS

被引：0
|
作者：
Murskyj, Ivanna O. [1 ]
Joy, Joydip [4 ]
Henkin, David R. [2 ]
Garza, Nina [3 ]
Shah, Vinay [3 ]
机构：
[1] Henry Ford Hosp, Internal Med, Troy, MI USA
[2] Henry Ford Hosp, Internal Med, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA
[4] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2020年 / 35卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [21] Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis
    de Freitas, Lucas Fernandes
    Feitosa, Marley Ribeiro
    Feres, Omar
    Parra, Rogerio Serafim
    [J]. INFLAMMATORY BOWEL DISEASES, 2021, 27 (02) : E15 - E17
  • [22] Pyoderma Gangrenosum in an Ulcerative Colitis Patient on Vedolizumab
    Choe, Sharon I.
    Bourgeois, Julien
    Nidamanuri, Sreecharita
    Rubenzik, Randi
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [23] Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis
    McLean, Leon P.
    Cross, Raymond K.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (07) : 833 - 842
  • [24] Disseminated histoplasmosis after alemtuzumab
    Siegrist, Emily A.
    Thomas, Cody
    Khawandanah, Mohamad
    Sassine, Joseph
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (06)
  • [25] Concomitant Use of Aminosalicylates Is Not Associated With Improved Outcomes in Patients With Ulcerative Colitis Escalated to Vedolizumab
    Ma, Christopher
    Kotze, Paulo G.
    Almutairdi, Abdulelah
    Jairath, Vipul
    Panaccione, Remo
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (11) : 2374 - +
  • [26] Disseminated Intravascular Coagulation in Ulcerative Colitis
    Saha, Sudip
    Bose, Kallol
    Das, Kallol
    Mridha, Dhrubojyoti
    Chakraborty, Chayan
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2016, 83 (06): : 594 - 595
  • [27] Reductions in Corticosteroid Use in Patients with Ulcerative Colitis or Crohn's Disease Treated with Vedolizumab
    Sands, Bruce
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Danese, Silvio
    Abreu, Maria
    Ahuja, Vineet
    Ponich, Terry
    Hilmi, Ida
    Sankoh, Serap
    Smyth, Michael
    Abhyankar, Brihad
    Fox, Irving
    Feagan, Brian
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S503 - S503
  • [28] Disseminated Intravascular Coagulation in Ulcerative Colitis
    Sudip Saha
    Kallol Bose
    Kallol Das
    Dhrubojyoti Mridha
    Chayan Chakraborty
    [J]. The Indian Journal of Pediatrics, 2016, 83 : 594 - 595
  • [29] Early Versus Late Use of Vedolizumab in Ulcerative Colitis: Clinical, Endoscopic, and Histological Outcomes
    Vermeire, Severine
    Hanzel, Jurij
    Lowenberg, Mark
    Ferrante, Marc
    Bossuyt, Peter
    Hoentjen, Frank
    Franchimont, Denis
    Palatka, Karoly
    Peeters, Harald
    Mookhoek, Aart
    de Hertogh, Gert
    Molnar, Tamas
    van Moerkercke, Wouter
    Lobaton, Triana
    Clasquin, Esme
    Hulshoff, Melanie S.
    Baert, Filip
    D'Haens, Geert
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (04): : 540 - 547
  • [30] Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis
    Dulai, Parambir S.
    Mosli, Mahmoud
    Khanna, Reena
    Levesque, Barrett G.
    Sandborn, William J.
    Feagan, Brian G.
    [J]. PHARMACOTHERAPY, 2015, 35 (04): : 412 - 423
12345